Mutation in TET2, an epigenetic regulator, was reported to promote HF, and transplantation of bone marrow with TET2‐deficient cells or conditional myeloid‐restrictive TET2 inactivation significantly augmented cardiac remodeling in mouse models of TAC‐ and chronic ischemia‐induced HF. This evidence concerns the gene TET2 and hydrops fetalis.